Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine on Working Memory in Mild to Moderate Depression
NCT06751784Phase 2Recruiting
- Sponsor
- University of Basel
- Start
- May 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in major depressive disorder (MDD), sponsored by University of Basel. Started May 2025; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06751784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06751784.